Navigation Links
Clinical trial first to test heart drug regimen for Duchenne muscular dystrophy
Date:6/26/2012

CINCINNATI The first landmark randomized clinical trial for a cardiac drug regimen in Duchenne muscular dystrophy (DMD) is testing whether earlier treatment can stop or slow down heart damage that usually kills people with the disease.

The study is a collaboration of Cincinnati Children's Hospital Medical Center, Ohio State University (OSU) and The Christ Hospital in Cincinnati.

Extensive research including studies in mouse models of DMD suggests an anti-fibrosis drug long used to treat heart attack victims, eplerenone, could help people with the disease, said Kan Hor, MD, a principal investigator and a physician/researcher at Cincinnati Children's.

Disease-associated heart damage is the leading cause of death in patients between ages 20 and 30 the maximum life span for people with DMD.

A key element of the new treatment approach is using enhanced cardiac magnetic resonance imaging, Hor said. The technique more sensitive than standard echocardiogram tests now used in DMD is designed to catch minute declines in heart function much earlier in a child's life.

"Standard diagnostic techniques rarely catch significant heart damage in DMD in the first decade, although research shows scar tissue is already developing in many patients before it's clinically detectable through current methods," said Hor, who works in the Cincinnati Children's Heart Institute. "We want to determine the optimal time point to detect these early changes in heart function and start cardiac therapy with anti-fibrotic medication."

A genetic disease that affects mostly boys, DMD is the most common form of muscular dystrophy. Most children begin losing the ability to walk between the ages of 7 and 13. With decades of research, testing and increased emphasis on multidisciplinary care, physicians have been able to use steroids and other drugs to preserve some ambulation, pulmonary function and push survival ages well into the
'/>"/>

Contact: Nick Miller
nicholas.miller@cchmc.org
513-803-6035
Cincinnati Children's Hospital Medical Center
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Mount Sinai is first in New York state to perform new Alzheimers imaging test in clinical setting
2. Snoring Isn't Sexy Member Dr. Mark Levy attends Academy of Clinical Sleep Disorders Disciplines Conference in Phoenix, Arizona
3. Psychoeducational intervention changes patient attitudes on clinical trials participation
4. Damon Runyon Cancer Research Foundation awards $3.3 million to 8 top young clinical investigators
5. Multi-center clinical study intensifies first strike at high-risk cancer in kids
6. Cleveland Clinic selected to participate in National MDS Clinical Research Consortium
7. Canada should significantly increase its funding of randomized clinical trials
8. Breast cancer clinical trial tests combo of heat shock protein inhibitor and hormonal therapy
9. Experts call for clinical trials to test non-skeletal benefits of vitamin D
10. Clinical news alert: Journal of the American Academy of Orthopaedic Surgeons May highlights
11. Automated insulin dosage titration system demonstrates positive clinical study results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... Caddis Partners LLC, has built one of the ... company in recent years, developing or acquiring 2 million ... including more than $100 million last year alone. , ... new geographic regions and a wider array of product ... announce an enhanced brand identity that includes a new ...
(Date:8/20/2014)... August 20, 2014 Braverman Eye Center ... help of their experienced surgeons trained in PresbyLasik. The ... regain their lost or inaccurate vision. Their diligent service ... surgery is making it possible for Presbyopia patients to ... occurs normally in people in the age group of ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 Texas Medical Research ... study. The study will help test the effectiveness of a ... from high cholesterol may be eligible to participate in the ... cholesterol in the blood can lead to cardiovascular disease, the ... cholesterol can help reduce the risk of heart disease and ...
(Date:8/20/2014)... Transrectal ultrasound guided biopsy is the gold standard for ... the number of risks associated with the procedure is ... found that six percent of men filled a prescription ... days after having a prostate biopsy, with a twofold ... The Journal of Urology . , Earlier studies reported ...
(Date:8/20/2014)... to predict both breast cancer relapses and responses ... gene. The newly found marker could help doctors ... treatment regimen that is more effective. The discovery ... Institute of Molecular and Cell Biology (IMCB), and ... at the National University of Singapore (NUS). , ...
Breaking Medicine News(10 mins):Health News:Caddis Rebrands to Emphasize Its Growth, Expanded Capabilities 2Health News:Caddis Rebrands to Emphasize Its Growth, Expanded Capabilities 3Health News:Caddis Rebrands to Emphasize Its Growth, Expanded Capabilities 4Health News:Braverman Eye Center Now Offers Multifocal PresbyLasik in Florida by Trained Surgeons 2Health News:Texas Medical Research Associates Announce New Study 2Health News:Severe infections with hospitalization after prostate biopsy rising in Sweden 2Health News:Novel gene predicts both breast cancer relapse and response to chemotherapy 2
... ,It,s Totally Glam to Go for a Mammogram, and ... Men ,Don,t Wait to Check Your Prostate, DALLAS, ... across Texas are sending a different kind of love note to ... women can send an e-reminder to,schedule important cancer screenings that will ...
... ... ... it has begun shipping the new SILVER SEAL(TM) Washable, Antimicrobial,Keyboard. According ... keyboard to be fully submersible, dishwasher safe,and manufactured from SILVER SEAL(TM) ...
... ARLINGTON, Va., Feb. 12 As health care,continues ... election, The HealthCentral,Network, Inc.,s ( http://www.HealthCentral.com ) interactive ... credible tool for voters to determine,which candidate aligns ... Now, washingtonpost.com has chosen the tool for its ...
... 12 Thanks to the collective spirit,of three ... new event has been added to the 2008 ... Triathlon, and registration,is now open., The Ramblin, ... empowerment of women, bring together women of all ...
... a,leading provider of evidence-based nutraceuticals for eye health, today,announced ... its Scientific,Advisory Board., Dr. Coleman is a Professor ... David Geffen School of Medicine at UCLA as well ... Health. She holds,the Frances and Ray Stark Endowed Chair ...
... Transitions, ... Feb. 12 In an effort to heighten,consumer awareness ... debuting a new print, broadcast and digital integrated advertising,campaign ... TV and in print,and will be supported by the ...
Cached Medicine News:Health News:'His and Hers' Screening Campaign Offers Unique Valentine's Day Message to Increase Cancer Screenings and Promote Health 2Health News:'His and Hers' Screening Campaign Offers Unique Valentine's Day Message to Increase Cancer Screenings and Promote Health 3Health News:Seal Shield Ships New SILVER SEAL(TM) Washable, Antimicrobial Keyboard 2Health News:Healthcentral's Healthcare08 Site, an Interactive Health Care Issues Tool, Featured on washingtonpost.com 2Health News:An Event Added to Celebrate and Empower North Carolina Women 2Health News:ScienceBased Health Appoints Anne L. Coleman, MD, PhD to Scientific Advisory Board 2Health News:Transitions Optical Promotes Healthy Sight Through a Nationwide Integrated Advertising Campaign and the Launch of an Enhanced Consumer Web Site 2Health News:Transitions Optical Promotes Healthy Sight Through a Nationwide Integrated Advertising Campaign and the Launch of an Enhanced Consumer Web Site 3
(Date:8/20/2014)... Aug. 20, 2014 Torrance Memorial Medical ... advanced, ventilator technology from Covidien to provide a ... patients. The acute care ventilator is ... to conventional mechanical ventilation, and help clinicians move ... Patients on mechanical ventilation are often sedated to ...
(Date:8/20/2014)... 2014 Transparency Market ... Acid (MCA) Market for Cellulosics, Agrochemicals, Surfactants, Thioglycolic Acid ... Share, Growth, Trends and Forecast 2014 - 2020". The ... million in 2013 and is anticipated to reach USD ... 3.6% during the forecast period from 2014 to 2020. ...
(Date:8/20/2014)... 2014 Reportlinker.com announces that a new ... Global Coatings for Medical Devices Industry ... This report analyzes the worldwide markets for ... the following Product Segments: Active Coatings, Protective Coatings, ... separate comprehensive analytics for the US, ...
Breaking Medicine Technology:Torrance Memorial Medical Center Acquires Advanced Ventilator Technology to Enhance Patient Care 2Global Monochloroacetic Acid (MCA) Market is Expected to Reach USD 1,046.7 million by 2020: Transparency Market Research 2Global Monochloroacetic Acid (MCA) Market is Expected to Reach USD 1,046.7 million by 2020: Transparency Market Research 3Global Monochloroacetic Acid (MCA) Market is Expected to Reach USD 1,046.7 million by 2020: Transparency Market Research 4Global Coatings for Medical Devices Industry 2Global Coatings for Medical Devices Industry 3Global Coatings for Medical Devices Industry 4Global Coatings for Medical Devices Industry 5Global Coatings for Medical Devices Industry 6Global Coatings for Medical Devices Industry 7Global Coatings for Medical Devices Industry 8Global Coatings for Medical Devices Industry 9Global Coatings for Medical Devices Industry 10Global Coatings for Medical Devices Industry 11Global Coatings for Medical Devices Industry 12Global Coatings for Medical Devices Industry 13Global Coatings for Medical Devices Industry 14Global Coatings for Medical Devices Industry 15Global Coatings for Medical Devices Industry 16Global Coatings for Medical Devices Industry 17Global Coatings for Medical Devices Industry 18Global Coatings for Medical Devices Industry 19Global Coatings for Medical Devices Industry 20Global Coatings for Medical Devices Industry 21
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: